Camp Lejeune Multiple Myeloma Lawsuit Filed By Son of Marine Stationed At Base in 1970s
The lawsuit blames Camp Lejeune water contamination for a U.S. Marine's son developing multiple myeloma.
Interested in the Camp Lejeune lawsuit?
Tag Archives: Multiple Myeloma
-
-
GSK Removes Blenrep From U.S. Market, Due Poor Clinical Trial Performance for Multiple Myeloma Drug
The multiple myeloma drug Blenrep is being removed from the U.S. market after the fast-tracked cancer drug failed to perform in a recent clinical trial.
-
Zometa Side Effects Increase Risk of Osteonecrosis of the Jaw: Study
A new study suggests frequent Zometa injections increase the risk of jawbone death for some cancer patients.
-
Venclexta Side Effects May Increase Risk Of Death In Multiple Myeloma Patients: FDA
The FDA warns that clinical trials indicate Venclexta can increase the risk of death when given off-label to patients for the treatment of multiple myeloma.
-
Homeowner Roundup Lawsuit Filed Over Multiple Myeloma Diagnosis
A Maine homeowner says he developed multiple myeloma after using Roundup to control weeds for years.
-
Kyprolis Side Effects May Increase Risks of Heart Problems, Researchers Warn
A new study warns that Kyprolis heart problems may be more widespread than previously believed.
-
Opdivo Multiple Myeloma Clinical Trials Halted Following Keytruda Deaths
After halting clinical trials involving the cancer drug Keytruda for treatment of multiple myeloma, the FDA has expanded the suspension to trials involving Opdivo, a similar medication.
-
Keytruda Side Effects in Multiple Myeloma Combo Treatment Poses Serious Risks: FDA
Two clinical trials have been halted and the FDA is warning that Keytruda side effects may increase the risk of death when used with other drugs to treat multiple myeloma.
-
Roundup Multiple Myeloma Lawsuit Filed Over Exposure to Weedkiller
A Roundup lawsuit indicates that using the weed killer at home and at work resulted in an Illinois man contracting multiple myeloma.
-
Side Effects of Revlimid May Increase Cancer Risk, FDA Warns
An FDA investigation into the potential side effects of Revlimid, a medication for treatment of multiple myeloma, suggests that users may face an increased risk of developing new types of…
